Patent · US Active

Clonidine compounds in a biodegradable polymer

US9610243B2 · kind B2 · utility

12Cited by

23References

9Claims

0Family size

Assignee

Warsaw Orthopedic, Inc.

Inventors

Danielle L. Clay · Collierville, US
Josee Roy · Memphis, US
William F. McKay · Memphis, US

Key dates

Filing date	Mar 15, 2013
Grant date	Apr 4, 2017
Priority date	—
Expiry date	Aug 14, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4162
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine in a drug depot at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate drug depot formulations are provided within biodegradable polymers, this pain relief can be continued for at least fourteen days.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.